Karl Landsteiner University of Health Sciences important study center. Data published in New England Journal of Medicine. Krems (Austria), 23. November 2023: Results from a recently published phase II clinical trial of an immunotherapeutic agent (Tarlatamab) for the treatment of small cell lung cancer have demo.
Research Team at the Karl Landsteiner University of Health Sciences develops novel protocol for studying isolated pairs of hippocampal neurons. Dedicated work honoured by cover page in Bio-protocol Journal. Krems (Austria), 29. August 2023 – Studying the complex interactions between synaptic nerve endings.